Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CETNYSE:HQLNASDAQ:NMFCNYSE:STEW On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCETCentral Securities$47.91+0.1%$46.19$40.24▼$49.51$1.39B0.8328,002 shs20,229 shsHQLabrdn Life Sciences Investors$12.90+0.7%$12.53$10.55▼$15.90$372.34M0.74107,062 shs131,150 shsNMFCNew Mountain Finance$10.58+0.3%$10.46$8.84▼$12.55$1.14B0.8471,617 shs597,250 shsSTEWSRH Total Return Fund$17.84+0.9%$17.37$14.32▼$17.89$1.72B0.96106,899 shs105,036 shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCETCentral Securities+0.19%+1.81%+2.99%+6.07%+8.72%HQLabrdn Life Sciences Investors+0.31%+2.77%+4.32%+3.94%-9.67%NMFCNew Mountain Finance+0.09%+2.53%-1.77%-4.87%-13.81%STEWSRH Total Return Fund+0.65%+2.05%+0.45%+2.34%+21.51%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCETCentral SecuritiesN/AN/AN/AN/AN/AN/AN/AN/AHQLabrdn Life Sciences InvestorsN/AN/AN/AN/AN/AN/AN/AN/ANMFCNew Mountain Finance1.8562 of 5 stars1.03.01.70.03.50.81.9STEWSRH Total Return FundN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCETCentral Securities 0.00N/AN/AN/AHQLabrdn Life Sciences Investors 0.00N/AN/AN/ANMFCNew Mountain Finance 2.00Hold$10.670.82% UpsideSTEWSRH Total Return Fund 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest HQL, STEW, NMFC, and CET Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/13/2025NMFCNew Mountain FinanceB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$11.005/12/2025NMFCNew Mountain FinanceB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold4/28/2025NMFCNew Mountain FinanceWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$11.00 ➝ $10.004/8/2025NMFCNew Mountain FinanceKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetMarket Perform ➝ Market Perform$12.00 ➝ $11.00(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCETCentral Securities$296.20M4.68N/AN/AN/A∞HQLabrdn Life Sciences InvestorsN/AN/AN/AN/AN/AN/ANMFCNew Mountain Finance$371.67M3.07$1.28 per share8.26$12.60 per share0.84STEWSRH Total Return FundN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCETCentral SecuritiesN/AN/A0.00∞N/AN/AN/AN/A8/12/2025 (Estimated)HQLabrdn Life Sciences InvestorsN/AN/A0.00∞N/AN/AN/AN/AN/ANMFCNew Mountain Finance$113.44M$1.0010.588.08N/A29.84%10.57%4.35%7/30/2025 (Estimated)STEWSRH Total Return FundN/AN/A0.00∞N/AN/AN/AN/A8/4/2025 (Estimated)Latest HQL, STEW, NMFC, and CET EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/5/2025Q1 2025NMFCNew Mountain Finance$0.32$0.32N/A$0.22$86.65 million$85.66 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCETCentral Securities$2.304.80%N/AN/AN/AHQLabrdn Life Sciences Investors$1.8914.65%N/AN/AN/ANMFCNew Mountain Finance$1.2812.10%N/A128.00%N/ASTEWSRH Total Return Fund$0.613.42%N/AN/AN/ALatest HQL, STEW, NMFC, and CET DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/9/2025STEWSRH Total Return Fundquarterly$0.16503.8%7/24/20257/24/20257/31/20255/20/2025HQLabrdn Life Sciences Investorsquarterly$0.4313.82%5/22/20255/22/20256/30/20254/22/2025NMFCNew Mountain Financequarterly$0.3212.6%6/16/20256/16/20256/30/20256/4/2025CETCentral Securitiesquarterly$0.252.14%6/17/20256/17/20256/27/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCETCentral SecuritiesN/AN/AN/AHQLabrdn Life Sciences InvestorsN/AN/AN/ANMFCNew Mountain Finance1.322.222.22STEWSRH Total Return FundN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCETCentral Securities8.68%HQLabrdn Life Sciences Investors32.21%NMFCNew Mountain Finance32.08%STEWSRH Total Return Fund15.61%Insider OwnershipCompanyInsider OwnershipCETCentral Securities9.50%HQLabrdn Life Sciences Investors10.06%NMFCNew Mountain Finance11.71%STEWSRH Total Return Fund0.09%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCETCentral Securities628.94 million26.19 millionNot OptionableHQLabrdn Life Sciences InvestorsN/A28.87 million25.97 millionNot OptionableNMFCNew Mountain FinanceN/A107.85 million95.22 millionOptionableSTEWSRH Total Return FundN/A96.51 million96.42 millionNot OptionableHQL, STEW, NMFC, and CET HeadlinesRecent News About These Companies26,087 Shares in SRH Total Return Fund, Inc. (NYSE:STEW) Acquired by Joel Isaacson & Co. LLCJune 30 at 5:21 AM | marketbeat.comOppenheimer & Co. Inc. Acquires 23,300 Shares of SRH Total Return Fund, Inc. (NYSE:STEW)June 28 at 3:39 AM | marketbeat.comConsolidated Portfolio Review Corp Acquires 59,857 Shares of SRH Total Return Fund, Inc. (NYSE:STEW)June 24, 2025 | marketbeat.comSRH Total Return Fund, Inc. (NYSE:STEW) Stock Position Lifted by Kingswood Wealth Advisors LLCJune 20, 2025 | marketbeat.comJP Wealth Management Inc. Has $16.71 Million Stake in SRH Total Return Fund, Inc. (NYSE:STEW)June 18, 2025 | marketbeat.com21,044 Shares in SRH Total Return Fund, Inc. (NYSE:STEW) Bought by Millennium Management LLCJune 11, 2025 | marketbeat.comSRH Total Return Fund, Inc. Declares Quarterly DistributionMay 8, 2025 | accessnewswire.comASTEW: A Cheaper Way To Own Berkshire HathawayMay 7, 2025 | seekingalpha.comSRH Total Return Fund Stock Dividends | NYSE:STEW | BenzingaMay 1, 2025 | benzinga.comSRH Total Return Fund, Inc. Section 19a NoticeApril 30, 2025 | gurufocus.comSRH Total Return Fund, Inc. Section 19a NoticeApril 30, 2025 | accessnewswire.comASRH Total Return Fund, Inc. Common Stock (STEW)April 23, 2025 | nasdaq.comBillionaire’s Fund Offers Cheap Play on Berkshire HathawayMarch 26, 2025 | msn.comSRH Total Return Fund, Inc. Declares Quarterly DistributionFebruary 21, 2025 | gurufocus.comSRH Total Return Fund, Inc. Declares Quarterly DistributionFebruary 20, 2025 | accessnewswire.comASTEW: Another Distribution Bump For This YearFebruary 18, 2025 | seekingalpha.comWhen (STEW) Moves Investors should ListenFebruary 8, 2025 | news.stocktradersdaily.comNSRH Total Return Fund, Inc. Section 19a NoticeJanuary 31, 2025 | accessnewswire.comAWhen the Price of (STEW) Talks, People ListenJanuary 28, 2025 | news.stocktradersdaily.comN(STEW) Trading AdviceJanuary 8, 2025 | news.stocktradersdaily.comNSTEW Update: Equity CEF With Low-Cost Fixed Leverage Continues To Perform WellDecember 10, 2024 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeHQL, STEW, NMFC, and CET Company DescriptionsCentral Securities NYSE:CET$47.91 +0.05 (+0.10%) As of 03:59 PM EasternCentral Securities Corp. is a publicly owned investment manager. The firm invests in the public equity markets of the United States. It also invests on bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks and corporations. Central Securities Corp. was founded on October 1, 1929 and is based in New York City.abrdn Life Sciences Investors NYSE:HQL$12.90 +0.09 (+0.68%) Closing price 03:59 PM EasternExtended Trading$12.90 +0.00 (+0.02%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.New Mountain Finance NASDAQ:NMFC$10.58 +0.03 (+0.28%) Closing price 04:00 PM EasternExtended Trading$10.58 +0.01 (+0.05%) As of 06:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.New Mountain Finance Corporation (Nasdaq: NMFC), a business development company is a private equity / buyouts and loan fund specializes in directly investing and lending to middle market companies in defensive growth industries. The fund prefers investing in buyout and middle market companies. It also makes investments in debt securities at all levels of the capital structure including first and second lien debt, unsecured notes, and mezzanine securities. In some cases, its investments may also include equity interests. It targets energy, engineering and consulting services, specialty chemicals and materials, trading companies and distributors, commercial printing, diversified support services, education services, environmental and facilities services, office services and supplies, media, distributors, health care services, health care facilities, application software, business services, systems software, federal services, distribution and logistics, interactive home entertainment, telecommunication services, hydroelectric power generation, electric power generation by fossil fuels, electric power generation by nuclear fuels, health care technology, and security and alarm services. The fund seeks to invest in United States of America. It seeks to invest between $10 million and $125 million per transaction. The firm invests through both primary originations and open-market secondary purchases. It invests in companies with EBITDA between $10 million and $200 million. The fund seeks a majority stake in its portfolio companies.SRH Total Return Fund NYSE:STEW$17.84 +0.16 (+0.90%) Closing price 03:58 PM EasternExtended Trading$17.84 0.00 (0.00%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SRH Total Return Fund, Inc. is a closed-ended balanced mutual fund launched and managed by Paralel Advisors LLC. Rocky Mountain Advisers, LLC serves as the Fund's sub-adviser. The fund invests in equity and fixed-income markets across the globe. It seeks to invest in securities of companies operating across diversified industries. The fund primarily invests in dividend-paying value stocks of companies across all capitalizations, as well as in fixed-income securities issued by companies. It employs both fundamental and quantitative analysis with a bottom-up security picking approach, focusing on such factors as defensible businesses with solid financial positions and strong operating track records to create its portfolio. The fund benchmarks the performance of its portfolio against the S&P 500 Composite Index. SRH Total Return Fund, Inc. is domiciled in the United States. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign Breakout Alert: Disney Stock Hits Multi-Year High 2 Under the Radar Space & Defense Stocks With Huge Potential Palantir’s $100M Nuclear OS Pact Boosts Bullish Case Forget IBM: Accenture’s AI Momentum Is Your Next Buy Joby Stock Soars as Piloted Flights in Dubai Signal a New Era Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 S&P 500 All-Time Highs: 5 Catalysts Driving It Higher Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
